Mar 6, 2013

Venture Fund Member Profile Share This Profile: NJTC Venture Fund makes catalytic seed, startup, and early stage venture capital investments. The firm actively partners with entrepreneurs to build unique, leading-edge businesses that drive superior returns for investors and economic growth in the community. NJTC Venture Fund invests in entrepreneurial teams building defensible, market-leading companies. NJTC Venture Fund is an active investor, providing from $250K to $5 million of capital over the course of a company's development. We have a preference to lead investments, typically in companies seeking from $1 to $10 million of capital to achieve profitable, sustainable growth. NJTC Venture Fund is a patient investor with a three to seven year horizon and an understanding that building industry leaders with long-term value takes time. Joe Falkstein General Partner NJTC Venture Fund Joe has more than 17 years of experience in the venture-backed, technology industry. Prior to NJTC Venture Fund, he was a partner in Andersen's Growth Company and Technology Practice, specializing in information technology, communications and healthcare services. Joe is a CPA and a graduate of Temple University. Joe represents the Fund on the Boards of Archive Systems, Datagence, and Microplate Automation. He also sits on the Boards of the New Jersey Technology Council, the Rutgers Venture Advisory Board, and the Greater Philadelphia Venture Group. Representative Investments AEP Networks AEP Networks (formerly Netilla Networks) is the specialist in network and application access security. AEP's integrated suite of solutions -- spanning identity-based application security gateways, highly secure IPSec VPNs, SSL VPNs, and hardware security modules for key management - address the most demanding security and access requirements of public-sector and commercial enterprises worldwide. Valera Pharmaceuticals Valera Pharmaceuticals focuses on developing, acquiring, and commercializing specialty pharmaceuticals and, through internal R&D and strategic partnerships, is advancing the state-of-art of drug delivery with its innovative Hydron™Implant technology. InMat InMat develops nanocomposite barrier coatings using an aqueous suspension platform comprised of nanoclays and polymers for use in sporting goods, tires, product packaging, and chemical protection devices. Game Trust Game Trust helps game publishers sell and publish games using its technology. Over 25 games have already been developed using Game Trust technology. The company also sells virtual merchandise through games, including "extra lives," extra characters or tournament play options. Joe participated in the FundingPost event: Perfect Venture Conferenceon April 5-7, 2006 in NY, Sponsored by Merrill Lynch, Morrison & Foerster, PPS for Healthcare To list your Company on our website and make your profile available to Joe and 7,500+ other VCs and Angel Investors, Click Here. About FundingPost For over Fourteen Years FundingPost has worked with thousandsof Angel and Venture Capital Investors. We believe that it isimportant to reach investors in every medium possible -both online and offline. We have been directly responsible fortons of success stories and Millions and Millions of dollars raised.We look forward to introducing your company to the leading Venture and Angel Investors nationwide. Sign up now: Entrepreneurs / Investors Join the FundingPost email list and learn how, when and where you can meet these Investors: Other Venture Profiles: